https://www.reuters.com/article/us-health-coronavirus-moderna-idUSKBN23535H

39 0

FILE PHOTO: A sign marks the headquarters of Moderna Therapeutics, which is developing a vaccine against the coronavirus disease (COVID-19), in Cambridge, Massachusetts, U.S., May 18, 2020. REUTERS/Brian Snyder. (Reuters) - Moderna Inc said on Friday it had started dosing patients in a mid-stage study with its experimental coronavirus vaccine and eventually plans to enroll 600 patients for the trial. There are currently about 10 coronavirus vaccines being tested in humans and experts have predicted that a safe and effective vaccine could take 12 to 18 months from the start of development. Earlier this month, Moderna had released here early-stage data that showed the vaccine, mRNA-1273, was... Full story

29 May

wait